
GENB vs PAHC
$GENB vs $PAHC head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GENB vs PAHC: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+4.4%). Split-adjusted daily closes.
- ·Neither kept up with the market over the past year: GENB -18% and PAHC -37.6%, against the S&P 500 at +4.4%.
- ·The last month has flipped the order: PAHC has held up better over the month (-13.2% against -20.9%) even though GENB leads over the year.
- ·PAHC has support 3.8% below at $32.77; GENB has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GENB vs PAHC: the quick read
- ·PAHC is the larger company by market cap ($1.38B vs $1.34B).
- ·GENB has been more active on our scanner (166 vs 40 alerts in 30 days).
- ·PAHC has the smaller float (21.0M vs 129.1M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·GENB draws far more of our scanner's attention, 166 unusual-volume alerts in 30 days against 40, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·PAHC pays a dividend and GENB does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching GENB or PAHC? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GENB and PAHC on TheDesperateTrader.
- Is GENB or PAHC the better stock?
- "Better" depends on your goal, and these two are not alike. PAHC is the larger company by market cap ($1.38B vs $1.34B). GENB has been more active on our scanner (166 vs 40 alerts in 30 days). PAHC has the smaller float (21.0M vs 129.1M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GENB and PAHC?
- The differences that matter: they are not in the same business - GENB is pharmaceutical preparations and PAHC is pharmaceutical preparations; they are similar in size ($1.34B vs $1.38B); they trade at very different share prices ($10.05 vs $34.08); GENB sits at 3% of its 52-week range against 18% for PAHC; only PAHC pays a dividend; our scanner flagged GENB 166 times in the last 30 days against 40 for PAHC. Everything above is measured from the latest completed session and SEC filings.
- Which of GENB and PAHC is more active right now?
- Right now GENB is at about 0.8x its normal volume and PAHC is at about 0.5x, so GENB is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GENB or PAHC in the stronger trend?
- GENB is below its 50-day average of $13.91; PAHC is below its 50-day average of $36.56 and below its 200-day average of $40.93. They split the head-to-head evenly, 2 measures each (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GENB or PAHC? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GENB and PAHC comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.